Rubedo Life Sciences to Launch Clinical Trial for RLS-1496 Hair Loss Treatment
Rubedo Life Sciences has announced a new clinical trial evaluating its investigational drug, RLS-1496, for the treatment of androgenetic alopecia, commonly known as male and female pattern baldness. Set to … Read More